YF-Vax Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with YF-Vax
H
- H-BIG (hepatitis b immune globulin)
- H.P. Acthar Gel (corticotropin)
- Hadlima (adalimumab)
- Halaven (eribulin)
- Hecoria (tacrolimus)
- Hemady (dexamethasone)
- HepaGam B (hepatitis b immune globulin)
- HepaGam B NovaPlus (hepatitis b immune globulin)
- hepatitis b immune globulin
- Hepzato (melphalan)
- Herceptin (trastuzumab)
- Herceptin Hylecta (hyaluronidase / trastuzumab)
- Hercessi (trastuzumab)
- Herzuma (trastuzumab)
- Hexadrol (dexamethasone)
- Hexalen (altretamine)
- HiDex (dexamethasone)
- Histolyn-Cyl (histoplasmin)
- histoplasmin
- Histoplasmin Diluted (histoplasmin)
- Hizentra (immune globulin subcutaneous)
- Hulio (adalimumab)
- Humira (adalimumab)
- hyaluronidase / immune globulin
- hyaluronidase / pertuzumab / trastuzumab
- hyaluronidase / rituximab
- hyaluronidase / trastuzumab
- Hycamtin (topotecan)
- Hydeltra-TBA (prednisolone)
- Hydeltrasol (prednisolone)
- Hydrea (hydroxyurea)
- hydrocortisone
- Hydrocortone (hydrocortisone)
- Hydrocortone Phosphate (hydrocortisone)
- hydroxyurea
- Hyftor (sirolimus topical)
- Hyper-Tet (tetanus immune globulin)
- Hyperhep (hepatitis b immune globulin)
- Hyperhep B (hepatitis b immune globulin)
- HyperRAB S/D (rabies immune globulin, human)
- HyperRHO S/D Full Dose (rho (d) immune globulin)
- HyperRHO S/D Mini-Dose (rho (d) immune globulin)
- HyperTET S/D (tetanus immune globulin)
- HypRho-D Mini-Dose (rho (d) immune globulin)
- Hyqvia (hyaluronidase / immune globulin)
- Hyrimoz (adalimumab)
More about YF-Vax (yellow fever vaccine)
- YF-Vax consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.